What is Custom Rx?
Custom Rx distinguishes itself in the healthcare sector by focusing exclusively on compounding unique, individualized prescriptions for patients. Unlike traditional pharmacies that primarily dispense mass-produced medications, Custom Rx revives the art of pharmaceutical compounding. This approach ensures that treatments are tailored to each patient's specific needs, addressing situations where standard 'one-size-fits-all' solutions are insufficient. The company's commitment to patient satisfaction, health, and safety is centered around its core competency: custom-compounded prescriptions.
How much funding has Custom Rx raised?
Custom Rx has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Custom Rx
PPP
Public-Private Partnership
What's next for Custom Rx?
Operating within a large-scale, late-stage funding context, Custom Rx is poised for significant expansion and market penetration. The recent major strategic investment signals confidence from backers in the company's unique business model and its ability to capture a larger share of the specialty pharmacy market. Future strategic initiatives will likely involve scaling operations, enhancing technological capabilities for compounding, and potentially broadening its network of healthcare providers who rely on its specialized services. This capital infusion is expected to fuel further innovation and solidify Custom Rx's position as a leader in personalized pharmaceutical care.
See full Custom Rx company page
